Ati cautat: studii clinice
Protocol terapeutic: J05AX18 – DCI LETERMOVIRUM (forma orală) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: H05AA03 – DCI PARATHYROID HORMONE (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: D11AH05 – DCI DUPILUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: B01AX07 – DCI CAPLACIZUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB15 – DCI VELMANAZA ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: R07AX30 – DCI LUMACAFTORUM+IVACAFTORUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L04AA25-SHUa – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L04AA25-HPN – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L01EK03 – DCI TIVOZANIBUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: A16AX08 – DCI TEDUGLUTIDUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
